Cargando…

The importance of time‐to‐adjuvant treatment on survival with pancreatic cancer: A systematic review and meta‐analysis

BACKGROUND: While adjuvant chemotherapy benefits patients with pancreatic ductal adenocarcinoma (PDAC), the importance of the time to initiation of adjuvant therapy remains unclear. AIM: This study seeks to better understand whether the timing of postoperative chemotherapy initiation affects long‐te...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugumar, Kavin, Hue, Jonathan J., De La Serna, Solanus, Rothermel, Luke D., Ocuin, Lee M., Hardacre, Jeffrey M., Ammori, John B., Winter, Jordan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552002/ https://www.ncbi.nlm.nih.gov/pubmed/34245139 http://dx.doi.org/10.1002/cnr2.1390

Ejemplares similares

The Impact of COVID-19 on Time-to-treatment in Pancreatic Adenocarcinoma: A Single Institutional Experience
por: Sugumar, Kavin, et al.
Publicado: (2021)

Immunotherapy Is Associated with a Survival Benefit in Patients Receiving Chemotherapy for Metastatic Pancreatic Cancer
por: Hue, Jonathan J., et al.
Publicado: (2021)

A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike?
por: Katayama, Erryk S., et al.
Publicado: (2020)

Targeting wild-type IDH1 enhances chemosensitivity in pancreatic cancer
por: Zarei, Mehrdad, et al.
Publicado: (2023)

Trends in Melanoma Phase 3 Clinical Trials since 2010: Is there Hope for Advanced Melanoma Therapies beyond Approved Treatment Mechanisms?
por: Kakish, Hanna H., et al.
Publicado: (2022)

The Role of the Microbiome in Gastroentero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs)
por: Mohamed, Amr, et al.
Publicado: (2022)

Completion Pancreaticoduodenectomy for a Second Primary Pancreatic Cancer: A Case Report
por: Hardacre, Jeffrey M.
Publicado: (2016)

Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database
por: Watson, Michael D., et al.
Publicado: (2020)

Wild-type IDH1 inhibition enhances chemotherapy response in melanoma
por: Zarei, Mehrdad, et al.
Publicado: (2022)

Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival
por: Morganti, Alessio G., et al.
Publicado: (2019)

Is there a Learning Curve for Pancreaticoduodenectomy after Fellowship Training?
por: Hardacre, Jeffrey M.
Publicado: (2010)

The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer
por: Kleeff, Jörg, et al.
Publicado: (2016)

Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic Entity
por: Rothermel, Luke D., et al.
Publicado: (2020)

Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital—Mayo Clinic Collaborative Study
por: Hsu, Charles C., et al.
Publicado: (2010)

Timing of Adjuvant Chemotherapy and Survival in Colorectal, Gastric, and Pancreatic Cancer. A Systematic Review and Meta-Analysis
por: Petrelli, Fausto, et al.
Publicado: (2019)

Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer
por: Ma, Sung Jun, et al.
Publicado: (2019)

The Addition of Chemoradiation to Adjuvant Chemotherapy is Associated With Improved Survival Following Upfront Surgical Resection for Pancreatic Cancer With Nodal Metastases
por: Altman, Ariella M., et al.
Publicado: (2022)

Increased Levels of Granulocytic Myeloid-Derived Suppressor Cells in Peripheral Blood and Tumour Tissue of Pancreatic Cancer Patients
por: Khaled, Yazan S., et al.
Publicado: (2014)

Metabolic Dependencies in Pancreatic Cancer
por: Vaziri-Gohar, Ali, et al.
Publicado: (2018)

Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer
por: Stocken, D D, et al.
Publicado: (2005)

Adjuvant chemotherapy followed by concurrent chemoradiation is associated with improved survival for resected stage I‐II pancreatic cancer
por: Ma, Sung Jun, et al.
Publicado: (2019)

Corrigendum: Metabolic Dependencies in Pancreatic Cancer
por: Vaziri-Gohar, Ali, et al.
Publicado: (2019)

Patient-centered Weight Tracking as an Early Cancer Detection Strategy
por: Hue, Jonathan J., et al.
Publicado: (2020)

The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis
por: Amin, Saber, et al.
Publicado: (2020)

Adjuvant chemotherapy in elderly patients with pancreatic cancer
por: Nagrial, A M, et al.
Publicado: (2014)

Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy
por: Annaberdyev, Shohrat, et al.
Publicado: (2009)

The importance of smoking cessation in pancreatitis
por: Han, Eunjong (Franklin), et al.
Publicado: (2022)

Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials
por: Nie, Run-Cong, et al.
Publicado: (2020)

Does adjuvant therapy reduce postmetastatic survival?
por: Fink, M K
Publicado: (2019)

Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors
por: Vaziri-Gohar, Ali, et al.
Publicado: (2022)

Population‐based study of the impact of surgical and adjuvant therapy at the same or a different institution on survival of patients with pancreatic adenocarcinoma
por: Latchana, N., et al.
Publicado: (2018)

DNA released from neutrophil extracellular traps (NETs) activates pancreatic stellate cells and enhances pancreatic tumor growth
por: Miller-Ocuin, Jennifer L., et al.
Publicado: (2019)

Inhibition of endoplasmic-reticulum-stress-mediated autophagy enhances the effectiveness of chemotherapeutics on pancreatic cancer
por: Thakur, Prakash C., et al.
Publicado: (2018)

The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms
por: Chand, Saswati, et al.
Publicado: (2016)

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy
por: Hsieh, Mao‐Chih, et al.
Publicado: (2018)

Outcomes of descemet stripping automated endothelial keratoplasty using imported donor corneas
por: Lekhanont, Kaevalin, et al.
Publicado: (2017)

Early Experience with a Hepatobiliary and Pancreatic Quality Improvement Program
por: O'Reilly, Derek, et al.
Publicado: (2013)

The spatial coexistence of TIGIT/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic ductal adenocarcinoma
por: Ma, Heng, et al.
Publicado: (2023)

Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
por: Lee, So Heun, et al.
Publicado: (2023)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5i3bcpsa1ehrb04mjef7btlk3k